News & Updates

Negative attitude towards MSM living with HIV tied to low knowledge, worry about HIV
Negative attitude towards MSM living with HIV tied to low knowledge, worry about HIV
08 Aug 2022 byStephen Padilla

Ignorance and fear of HIV both contribute significantly to the negative attitudes towards men who have sex with men (MSM) living with the virus, suggests a study presented at the 24th International AIDS Conference (AIDS 2022) in Montreal, Canada.

Negative attitude towards MSM living with HIV tied to low knowledge, worry about HIV
08 Aug 2022
Long-acting injectable HIV drug works for all ages
Long-acting injectable HIV drug works for all ages
07 Aug 2022 byJairia Dela Cruz

The long-acting combination of cabotegravir plus rilpivirine, administered as monthly or once-every-2-months jabs, appears to be effective in both older and younger patients living with HIV, with most maintaining virologic suppression through week 96, according to pooled data from the phase III ATLAS, FLAIR, and ATLAS-2M studies.

Long-acting injectable HIV drug works for all ages
07 Aug 2022
Tenofovir in mothers plus HBIG in infants best prevent vertical HBV transmission
Tenofovir in mothers plus HBIG in infants best prevent vertical HBV transmission
07 Aug 2022

For mothers with hepatitis B virus (HBV) infection who are positive for both hepatitis B surface and envelope antigens, administering a combination of hepatitis B vaccine and immunoglobulin (HBIG) in their infants plus tenofovir disoproxil fumarate (TDF) in the mothers themselves appears to be the best approach for preventing vertical disease transmission, according to a study.

Tenofovir in mothers plus HBIG in infants best prevent vertical HBV transmission
07 Aug 2022
HIV intervention uptake remains low among transgender men; campaign helps
HIV intervention uptake remains low among transgender men; campaign helps
05 Aug 2022 byStephen Padilla

Transgender individuals, particularly transgender men (TGM), show poor acceptance of HIV prevention interventions (HPI) in the Philippines, according to a study presented at the AIDS 2022 conference in Montreal, Canada. Although some transgender individuals who prefer having sex with men make use of HPI, it remains relatively lower among TGM who have sex with men (SM).

HIV intervention uptake remains low among transgender men; campaign helps
05 Aug 2022
Expectant mums’ use of dolutegravir safe for babies
Expectant mums’ use of dolutegravir safe for babies
04 Aug 2022 byJairia Dela Cruz

Treatment with dolutegravir during pregnancy does not appear to pose an excess risk of adverse birth outcomes, according to two studies presented at the 24th International AIDS Conference in Montreal, Canada.

Expectant mums’ use of dolutegravir safe for babies
04 Aug 2022
Treatment regimen based on small RNAi safe, effective in chronic hepatitis B
Treatment regimen based on small RNAi safe, effective in chronic hepatitis B
03 Aug 2022

In patients with chronic hepatitis B (CHB), treatment with the small interfering RNA JNJ-3989, in combination with a nucleos(t)ide analogue (NA), safely reduces levels of the hepatitis B surface antigen (HBsAg) for up to almost a year after the last dose, a new study has found.

Treatment regimen based on small RNAi safe, effective in chronic hepatitis B
03 Aug 2022